Is C4 Therapeutics, Inc. overvalued?

C4 Therapeutics, Inc. (CCCC) — key valuation metrics and fundamentals.

No verdict

Price

$2.76

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$362.4M

Dividend yield

0.0%

Return on equity

-37.7%

Sector

Healthcare

Fair value compares CCCC's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks